Related Experiment Videos
Rickettsial vaccines: the old and the new
1Rickettsial Diseases Department, Naval Medical Research Center, RDD/IDD Rm 3S04B, 503 Robert Grant Avenue, Silver Spring, MD 20910-7500, USA. RichardsA@nmrc.navy.mil
Expert Review of Vaccines
|October 16, 2004
Summary
Vaccine development for rickettsial diseases has stalled, with no new vaccines licensed in 20 years. Modern molecular biology offers a path to safe, affordable, and effective rickettsial vaccines.
Area of Science:
- Infectious Diseases
- Vaccinology
- Molecular Biology
Background:
- Rickettsial diseases pose a significant public health threat, necessitating effective preventive strategies.
- Vaccine development for rickettsial infections has a long history, with numerous attempts over the past century.
Observation:
- Despite historical efforts, no new rickettsial vaccines have been manufactured or licensed in the last two decades.
- Previous rickettsial vaccines were associated with production challenges, high costs, and significant safety concerns.
Findings:
- Current advancements in molecular biology are enabling the development of novel rickettsial vaccines.
- These new vaccine candidates are designed to be standardized, cost-effective, and safe for production and administration.
Implications:
- The successful development of these modern vaccines could overcome the limitations of earlier approaches.
- This could lead to the availability of efficacious rickettsial vaccines, improving disease prevention and control globally.